TY - JOUR AU - Firestein, G. S. PY - 2003 DA - 2003// TI - Evolving concepts of rheumatoid arthritis JO - Nature VL - 423 UR - https://doi.org/10.1038/nature01661 DO - 10.1038/nature01661 ID - Firestein2003 ER - TY - JOUR AU - Zhao, X. AU - Okeke, N. L. AU - Sharpe, O. AU - Batliwalla, F. M. AU - Lee, A. T. AU - Ho, P. P. PY - 2008 DA - 2008// TI - Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis JO - Arthritis Res Ther VL - 10 UR - https://doi.org/10.1186/ar2478 DO - 10.1186/ar2478 ID - Zhao2008 ER - TY - JOUR AU - Clavel, C. AU - Nogueira, L. AU - Laurent, L. AU - Iobagiu, C. AU - Vincent, C. AU - Sebbag, M. PY - 2008 DA - 2008// TI - Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23284 DO - 10.1002/art.23284 ID - Clavel2008 ER - TY - JOUR AU - Edwards, J. C. AU - Szczepanski, L. AU - Szechinski, J. AU - Filipowicz-Sosnowska, A. AU - Emery, P. AU - Close, D. R. PY - 2004 DA - 2004// TI - Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa032534 DO - 10.1056/NEJMoa032534 ID - Edwards2004 ER - TY - JOUR AU - Daien, C. I. AU - Gailhac, S. AU - Mura, T. AU - Audo, R. AU - Combe, B. AU - Hahne, M. PY - 2014 DA - 2014// TI - Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity JO - Arthritis Rheumatol VL - 66 UR - https://doi.org/10.1002/art.38666 DO - 10.1002/art.38666 ID - Daien2014 ER - TY - JOUR AU - Satterthwaite, A. B. AU - Witte, O. N. PY - 2000 DA - 2000// TI - The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective JO - Immunol Rev. VL - 175 UR - https://doi.org/10.1111/j.1600-065X.2000.imr017504.x DO - 10.1111/j.1600-065X.2000.imr017504.x ID - Satterthwaite2000 ER - TY - JOUR AU - Humphries, L. A. AU - Dangelmaier, C. AU - Sommer, K. AU - Kipp, K. AU - Kato, R. M. AU - Griffith, N. PY - 2004 DA - 2004// TI - Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma Src homology 2-Src homology 3 linker JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M311985200 DO - 10.1074/jbc.M311985200 ID - Humphries2004 ER - TY - JOUR AU - Bishop, G. A. AU - Hostager, B. S. PY - 2001 DA - 2001// TI - B lymphocyte activation by contact-mediated interactions with T lymphocytes JO - Curr Opin Immunol VL - 13 UR - https://doi.org/10.1016/S0952-7915(00)00216-8 DO - 10.1016/S0952-7915(00)00216-8 ID - Bishop2001 ER - TY - JOUR AU - Koprulu, A. D. AU - Ellmeier, W. PY - 2009 DA - 2009// TI - The role of Tec family kinases in mononuclear phagocytes JO - Crit Rev Immunol VL - 29 UR - https://doi.org/10.1615/CritRevImmunol.v29.i4.30 DO - 10.1615/CritRevImmunol.v29.i4.30 ID - Koprulu2009 ER - TY - JOUR AU - Jongstra-Bilen, J. AU - Puig Cano, A. AU - Hasija, M. AU - Xiao, H. AU - Smith, C. I. AU - Cybulsky, M. I. PY - 2008 DA - 2008// TI - Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.1.288 DO - 10.4049/jimmunol.181.1.288 ID - Jongstra-Bilen2008 ER - TY - JOUR AU - Tai, Y. T. AU - Chang, B. Y. AU - Kong, S. Y. AU - Fulciniti, M. AU - Yang, G. AU - Calle, Y. PY - 2012 DA - 2012// TI - Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2011-12-396853 DO - 10.1182/blood-2011-12-396853 ID - Tai2012 ER - TY - JOUR AU - Shinohara, M. AU - Chang, B. Y. AU - Buggy, J. J. AU - Nagai, Y. AU - Kodama, T. AU - Asahara, H. PY - 2014 DA - 2014// TI - The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss JO - Bone. VL - 60 UR - https://doi.org/10.1016/j.bone.2013.11.025 DO - 10.1016/j.bone.2013.11.025 ID - Shinohara2014 ER - TY - JOUR AU - Brand, D. D. AU - Latham, K. A. AU - Rosloniec, E. F. PY - 2007 DA - 2007// TI - Collagen-induced arthritis JO - Nat Protoc VL - 2 UR - https://doi.org/10.1038/nprot.2007.173 DO - 10.1038/nprot.2007.173 ID - Brand2007 ER - TY - JOUR AU - Kitanaka, A. AU - Mano, H. AU - Conley, M. E. AU - Campana, D. PY - 1998 DA - 1998// TI - Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells JO - Blood VL - 91 ID - Kitanaka1998 ER - TY - JOUR AU - Paolo, J. A. AU - Huang, T. AU - Balazs, M. AU - Barbosa, J. AU - Barck, K. H. AU - Bravo, B. J. PY - 2011 DA - 2011// TI - Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis JO - Nat Chem Biol VL - 7 UR - https://doi.org/10.1038/nchembio.481 DO - 10.1038/nchembio.481 ID - Paolo2011 ER - TY - JOUR AU - Wang, J. AU - Lau, K. Y. AU - Jung, J. AU - Ravindran, P. AU - Barrat, F. J. PY - 2014 DA - 2014// TI - Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells JO - Eur J Immunol VL - 44 UR - https://doi.org/10.1002/eji.201344030 DO - 10.1002/eji.201344030 ID - Wang2014 ER - TY - STD TI - Byrd JC, Harrington B, O'Brien S, Jones JA, Schuh A, Devereux S, et al. Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia. N Engl J Med. 2015. ID - ref17 ER - TY - JOUR AU - Turner, N. C. AU - Ro, J. AU - Andre, F. AU - Loi, S. AU - Verma, S. AU - Iwata, H. PY - 2015 DA - 2015// TI - Palbociclib in hormone-receptor-positive advanced breast cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1505270 DO - 10.1056/NEJMoa1505270 ID - Turner2015 ER - TY - JOUR AU - Hussain, A. AU - Yu, L. AU - Faryal, R. AU - Mohammad, D. K. AU - Mohamed, A. J. AU - Smith, C. I. PY - 2011 DA - 2011// TI - TEC family kinases in health and disease – loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK JO - FEBS J VL - 278 UR - https://doi.org/10.1111/j.1742-4658.2011.08134.x DO - 10.1111/j.1742-4658.2011.08134.x ID - Hussain2011 ER - TY - JOUR AU - Finnegan, A. AU - Ashaye, S. AU - Hamel, K. M. PY - 2012 DA - 2012// TI - B effector cells in rheumatoid arthritis and experimental arthritis JO - Autoimmunity VL - 45 UR - https://doi.org/10.3109/08916934.2012.665526 DO - 10.3109/08916934.2012.665526 ID - Finnegan2012 ER - TY - JOUR AU - Wang, Q. AU - Ma, Y. AU - Liu, D. AU - Zhang, L. AU - Wei, W. PY - 2011 DA - 2011// TI - The roles of B cells and their interactions with fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis JO - Int Arch Allergy Immunol VL - 155 UR - https://doi.org/10.1159/000321185 DO - 10.1159/000321185 ID - Wang2011 ER - TY - JOUR AU - Edwards, J. C. AU - Cambridge, G. PY - 2001 DA - 2001// TI - Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes JO - Rheumatology (Oxford) VL - 40 UR - https://doi.org/10.1093/rheumatology/40.2.205 DO - 10.1093/rheumatology/40.2.205 ID - Edwards2001 ER - TY - JOUR AU - Cohen, S. B. AU - Emery, P. AU - Greenwald, M. W. AU - Dougados, M. AU - Furie, R. A. AU - Genovese, M. C. PY - 2006 DA - 2006// TI - Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22025 DO - 10.1002/art.22025 ID - Cohen2006 ER - TY - JOUR AU - Chatzidionysiou, K. AU - Lie, E. AU - Nasonov, E. AU - Lukina, G. AU - Hetland, M. L. AU - Tarp, U. PY - 2011 DA - 2011// TI - Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.148759 DO - 10.1136/ard.2010.148759 ID - Chatzidionysiou2011 ER - TY - JOUR AU - Chang, B. Y. AU - Huang, M. M. AU - Francesco, M. AU - Chen, J. AU - Sokolove, J. AU - Magadala, P. PY - 2011 DA - 2011// TI - The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells JO - Arthritis Res Ther VL - 13 UR - https://doi.org/10.1186/ar3400 DO - 10.1186/ar3400 ID - Chang2011 ER - TY - JOUR AU - Xu, D. AU - Kim, Y. AU - Postelnek, J. AU - Vu, M. D. AU - Hu, D. Q. AU - Liao, C. PY - 2012 DA - 2012// TI - RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents JO - J Pharmacol Exp Ther VL - 341 UR - https://doi.org/10.1124/jpet.111.187740 DO - 10.1124/jpet.111.187740 ID - Xu2012 ER - TY - JOUR AU - Aalipour, A. AU - Advani, R. H. PY - 2014 DA - 2014// TI - Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib JO - Ther Adv Hematol VL - 5 UR - https://doi.org/10.1177/2040620714539906 DO - 10.1177/2040620714539906 ID - Aalipour2014 ER - TY - JOUR AU - Genevier, H. C. AU - Hinshelwood, S. AU - Gaspar, H. B. AU - Rigley, K. P. AU - Brown, D. AU - Saeland, S. PY - 1994 DA - 1994// TI - Expression of Bruton's tyrosine kinase protein within the B cell lineage JO - Eur J Immunol VL - 24 UR - https://doi.org/10.1002/eji.1830241228 DO - 10.1002/eji.1830241228 ID - Genevier1994 ER - TY - JOUR AU - Koivuniemi, R. AU - Leirisalo-Repo, M. AU - Suomalainen, R. AU - Piirainen, H. AU - Paimela, L. PY - 2006 DA - 2006// TI - Infectious causes of death in patients with rheumatoid arthritis: an autopsy study JO - Scand J Rheumatol VL - 35 UR - https://doi.org/10.1080/03009740600556258 DO - 10.1080/03009740600556258 ID - Koivuniemi2006 ER - TY - JOUR AU - Kim, S. Y. AU - Solomon, D. H. PY - 2010 DA - 2010// TI - Tumor necrosis factor blockade and the risk of viral infection JO - Nat Rev Rheumatol VL - 6 UR - https://doi.org/10.1038/nrrheum.2009.279 DO - 10.1038/nrrheum.2009.279 ID - Kim2010 ER - TY - JOUR AU - Jefferies, C. A. AU - Doyle, S. AU - Brunner, C. AU - Dunne, A. AU - Brint, E. AU - Wietek, C. PY - 2003 DA - 2003// TI - Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4 JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M301484200 DO - 10.1074/jbc.M301484200 ID - Jefferies2003 ER - TY - JOUR AU - Marron, T. U. AU - Rohr, K. AU - Martinez-Gallo, M. AU - Yu, J. AU - Cunningham-Rundles, C. PY - 2010 DA - 2010// TI - TLR signaling and effector functions are intact in XLA neutrophils JO - Clin Immunol VL - 137 UR - https://doi.org/10.1016/j.clim.2010.06.011 DO - 10.1016/j.clim.2010.06.011 ID - Marron2010 ER - TY - JOUR AU - Zorn, C. N. AU - Keck, S. AU - Hendriks, R. W. AU - Leitges, M. AU - Freudenberg, M. A. AU - Huber, M. PY - 2009 DA - 2009// TI - Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells JO - Cell Signal VL - 21 UR - https://doi.org/10.1016/j.cellsig.2008.09.010 DO - 10.1016/j.cellsig.2008.09.010 ID - Zorn2009 ER - TY - JOUR AU - Christensen, S. R. AU - Kashgarian, M. AU - Alexopoulou, L. AU - Flavell, R. A. AU - Akira, S. AU - Shlomchik, M. J. PY - 2005 DA - 2005// TI - Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus JO - J Exp Med VL - 202 UR - https://doi.org/10.1084/jem.20050338 DO - 10.1084/jem.20050338 ID - Christensen2005 ER - TY - JOUR AU - Bowie, A. G. AU - Unterholzner, L. PY - 2008 DA - 2008// TI - Viral evasion and subversion of pattern-recognition receptor signalling JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2436 DO - 10.1038/nri2436 ID - Bowie2008 ER - TY - JOUR AU - Ramos-Casals, M. AU - Soto, M. J. AU - Cuadrado, M. J. AU - Khamashta, M. A. PY - 2009 DA - 2009// TI - Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases JO - Lupus VL - 18 UR - https://doi.org/10.1177/0961203309106174 DO - 10.1177/0961203309106174 ID - Ramos-Casals2009 ER - TY - JOUR AU - Terrier, B. AU - Amoura, Z. AU - Ravaud, P. AU - Hachulla, E. AU - Jouenne, R. AU - Combe, B. PY - 2010 DA - 2010// TI - Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry JO - Arthritis Rheum VL - 62 UR - https://doi.org/10.1002/art.27541 DO - 10.1002/art.27541 ID - Terrier2010 ER - TY - JOUR AU - Ng, K. P. AU - Cambridge, G. AU - Leandro, M. J. AU - Edwards, J. C. AU - Ehrenstein, M. AU - Isenberg, D. A. PY - 2007 DA - 2007// TI - B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.067124 DO - 10.1136/ard.2006.067124 ID - Ng2007 ER - TY - JOUR AU - Stone, J. H. AU - Merkel, P. A. AU - Spiera, R. AU - Seo, P. AU - Langford, C. A. AU - Hoffman, G. S. PY - 2010 DA - 2010// TI - Rituximab versus cyclophosphamide for ANCA-associated vasculitis JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0909905 DO - 10.1056/NEJMoa0909905 ID - Stone2010 ER - TY - JOUR AU - Specks, U. AU - Merkel, P. A. AU - Seo, P. AU - Spiera, R. AU - Langford, C. A. AU - Hoffman, G. S. PY - 2013 DA - 2013// TI - Efficacy of remission-induction regimens for ANCA-associated vasculitis JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1213277 DO - 10.1056/NEJMoa1213277 ID - Specks2013 ER -